Hangjun Zhan
Chief Technology Officer @ Attovia Therapeutics
United States
San Mateo
Biotechnology
Biomarkers, Lifesciences, Drug Development, Clinical Development, Oncology, Biotechnology, Drug Discovery, Biochemistry, Assay Development, Biopharmaceuticals, Antibodies, Pharmaceutical Industry, Immunology, ELISA, Medicinal Chemistry, IND, Technology Transfer, High Throughput Screening, Monoclonal Antibodies, Protein Purification
Experience
Chief Technology Officer
Attovia Therapeutics
CSO
Alamar Biosciences, Inc.
CSO
KindredBio_ELANCO (Nasdaq: ELAN)
CSO and Officer
KindredBio (Nasdaq: KIN)
SVP: VP and Head of Biologics Research
KindredBio (Nasdaq: KIN)
Director (Executive)
Aragen Bioscience
Sr. Director
Exelixis Inc (Nasdaq: EXEL)
SSF
Group Leader
Celera Genomics (Nasdaq: CRA; AXYS: ARRS)
Education
Harvard Medical School
Protein Biophysics
University of Washington
Biochem
Zhejiang University
Hangjun Zhan's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.